Correlation Between Caribou Biosciences and Theseus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Theseus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Theseus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Theseus Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and Theseus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Theseus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Theseus Pharmaceuticals.
Diversification Opportunities for Caribou Biosciences and Theseus Pharmaceuticals
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Caribou and Theseus is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Theseus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theseus Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Theseus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theseus Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Theseus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Theseus Pharmaceuticals
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Theseus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.58 times less risky than Theseus Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Theseus Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 566.00 in Theseus Pharmaceuticals on August 30, 2024 and sell it today you would lose (195.00) from holding Theseus Pharmaceuticals or give up 34.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 31.31% |
| Values | Daily Returns |
Caribou Biosciences vs. Theseus Pharmaceuticals
Performance |
| Timeline |
| Caribou Biosciences |
| Theseus Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Caribou Biosciences and Theseus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and Theseus Pharmaceuticals
The main advantage of trading using opposite Caribou Biosciences and Theseus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Theseus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theseus Pharmaceuticals will offset losses from the drop in Theseus Pharmaceuticals' long position.| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
| Theseus Pharmaceuticals vs. Relay Therapeutics | Theseus Pharmaceuticals vs. Century Therapeutics | Theseus Pharmaceuticals vs. Blueprint Medicines Corp | Theseus Pharmaceuticals vs. Pmv Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |